A pilot study of the comparative bioavailability of estradiol from two different estradiol transdermal systems: Oesclim® 50 and Systen® 50
Open Access
- 31 October 1995
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 56 (10) , 1022-1032
- https://doi.org/10.1016/0011-393x(95)85108-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Transdermal EstradiolDrugs, 1990
- Comparative metabolic study of percutaneous versus oral micronized 17β-oestradiol in replacement therapyMaturitas, 1989
- Pharmacokinetic Considerations in the Use of Newer Transdermal FormulationsClinical Pharmacokinetics, 1988
- Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women.BMJ, 1986
- Biological Effects of Estradiol-17β in Postmenopausal Women: Oral Versus percutaneous AdministrationJournal of Clinical Endocrinology & Metabolism, 1986
- Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacementAmerican Journal of Obstetrics and Gynecology, 1985
- Reference weights: Practical considerationsThe American Journal of Medicine, 1984
- A Methodological Critique of the 'Ideal Weight' ConceptJAMA, 1983